University of Texas Southwestern Medical Center - Accepting Juvenile Patients, Dallas
Houston Methodist Hospital - Accepting Adult Patients, Houston
University of Texas MD Anderson Cancer Center - Accepting Adult Patients, Houston

A’ fastadhÌre 2/3

Aoisean 6 gu 75 · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT06154252

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

Baylor College of Medicine, Houston

A’ fastadhÌre 3

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT06948318

A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

GSK Investigational Site, Houston
GSK Investigational Site, Temple

A’ fastadhÌre 3

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT06572384

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

University of Texas MD Anderson Cancer Center, Houston

A’ fastadhÌre 1/2

Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 26 Lùna 2026 · NCT06121297

Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.

Dallas Renal Group, Dallas
Dallas Renal Group, Dallas
Nephro Asso North Illinois Indiana, Houston

A’ fastadhÌre 3

Aoisean 18 gu 100 · Gach gnè · Air ùrachadh 17 Lùna 2026 · NCT06858319

Music-4-MS to Improve Cognition in People Living With Multiple Sclerosis: A Feasibility Study

University of Texas at Austin, Austin

A’ fastadh

Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 17 Lùna 2026 · NCT07759115

RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis

Baylor College of Medicine Neurology Department, Houston
Houston Methodist Hospital, Houston
University of Texas MD Anderson Cancer Center, Houston

A’ fastadhÌre 1/2

Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 13 Lùna 2026 · NCT06359041

A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections

UT Southwestern Medical Center, Dallas
Cook Children's Medical Center, Fort Worth
Texas Children's Hospital/ Baylor College of Medicine, Houston
agus 1 a bharrachd

A’ fastadhÌre 3

Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 6 Lùna 2026 · NCT06056297

Study of BHV-1300 in Graves' Disease

Site-109, Dallas
Site-106, Houston
Site-101, Houston
agus 1 a bharrachd

A’ fastadhÌre 1

Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 31 Iuch 2026 · NCT06980649

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

Site Number - 1003, Dallas
Site Number - 1047, Denton
Site Number - 1057, Houston
agus 1 a bharrachd

A’ fastadhÌre 3

Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 30 Iuch 2026 · NCT07039916

KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis

Houston Methodist Hospital, Houston

A’ fastadhÌre 2/3

Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 29 Iuch 2026 · NCT06193889

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Medical City Dallas, Dallas
Children's Medical Center Dallas, Dallas
Zachary & Elizabeth Fisher Bone Marrow Transplant Program (Brooke Army Medical Center), Fort Sam Houston
agus 5 a bharrachd

A’ fastadhSgrùdadh amharc

Gach aois · Gach gnè · Air ùrachadh 6 Iuch 2026 · NCT01351545

A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)

UT Southwestern Medical Center, Dept. of Dermatology, Dallas
MD Anderson Texas Medical Center, Houston

A’ fastadhÌre 1/2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Cèit 2026 · NCT04422912

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M D Anderson Cancer Center, Houston

A’ fastadhSgrùdadh amharc

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Cèit 2026 · NCT04751396

Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

MD Anderson Cancer Center, Houston
The University of Texas Health Science Center at Houston, Houston

A’ fastadhÌre 1/2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Gibl 2026 · NCT06434363

A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

UT Southwestern Medical Center, Dallas
Houston Methodist Hospital, Houston

A’ fastadhÌre 1

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Gearr 2026 · NCT06626919

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.